These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28567317)

  • 1. Open-Label Fosmetpantotenate, a Phosphopantothenate Replacement Therapy in a Single Patient with Atypical PKAN.
    Christou YP; Tanteles GA; Kkolou E; Ormiston A; Konstantopoulos K; Beconi M; Marshall RD; Plotkin H; Kleopa KA
    Case Rep Neurol Med; 2017; 2017():3247034. PubMed ID: 28567317
    [No Abstract]   [Full Text] [Related]  

  • 2. Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase-Associated Neurodegeneration.
    Klopstock T; Videnovic A; Bischoff AT; Bonnet C; Cif L; Comella C; Correa-Vela M; Escolar ML; Fraser JL; Gonzalez V; Hermanowicz N; Jech R; Jinnah HA; Kmiec T; Lang A; Martí MJ; Mercimek-Andrews S; Monduy M; Nimmo GAM; Perez-Dueñas B; Pfeiffer HCV; Planellas L; Roze E; Thakur N; Tochen L; Vanegas-Arroyave N; Zorzi G; Burns C; Greblikas F
    Mov Disord; 2021 Jun; 36(6):1342-1352. PubMed ID: 33200489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient and caregiver experiences with pantothenate kinase-associated neurodegeneration (PKAN): results from a patient community survey.
    Klopstock T; Mercimek-Andrews S; Jurecka A; Wood P; Cwyl M; Klucken A; López A; Scalise R; Valle A; Mollet F; Perez-Duenas B; Skowronska M; Chroscinska-Krawczyk M; Escolar ML; Wade A; Rintell D
    Orphanet J Rare Dis; 2023 Aug; 18(1):257. PubMed ID: 37653408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational Design of Novel Therapies for Pantothenate Kinase-Associated Neurodegeneration.
    Thakur N; Klopstock T; Jackowski S; Kuscer E; Tricta F; Videnovic A; Jinnah HA
    Mov Disord; 2021 Sep; 36(9):2005-2016. PubMed ID: 34002881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel PANK2 Mutation in a Patient with Atypical Pantothenate-Kinase-Associated Neurodegeneration Presenting with Adult-Onset Parkinsonism.
    Seo JH; Song SK; Lee PH
    J Clin Neurol; 2009 Dec; 5(4):192-4. PubMed ID: 20076801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision medicine in pantothenate kinase-associated neurodegeneration.
    Alvarez-Cordoba M; Villanueva-Paz M; Villalón-García I; Povea-Cabello S; Suárez-Rivero JM; Talaverón-Rey M; Abril-Jaramillo J; Vintimilla-Tosi AB; Sánchez-Alcázar JA
    Neural Regen Res; 2019 Jul; 14(7):1177-1185. PubMed ID: 30804242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The FOsmetpantotenate Replacement Therapy (FORT) randomized, double-blind, Placebo-controlled pivotal trial: Study design and development methodology of a novel primary efficacy outcome in patients with pantothenate kinase-associated neurodegeneration.
    Klopstock T; Escolar ML; Marshall RD; Perez-Dueñas B; Tuller S; Videnovic A; Greblikas F
    Clin Trials; 2019 Aug; 16(4):410-418. PubMed ID: 31055958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel homozygous PANK2 mutation causing atypical pantothenate kinase-associated neurodegeneration (PKAN) in a Cypriot family.
    Tanteles GA; Spanou-Aristidou E; Antoniou C; Christophidou-Anastasiadou V; Kleopa KA
    J Neurol Sci; 2014 May; 340(1-2):233-6. PubMed ID: 24655737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models.
    Elbaum D; Beconi MG; Monteagudo E; Di Marco A; Quinton MS; Lyons KA; Vaino A; Harper S
    PLoS One; 2018; 13(3):e0192028. PubMed ID: 29522513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and Treatment of Pantothenate Kinase-Associated Neurodegeneration (PKAN): A Systematic Review.
    Pohane MR; Dafre R; Sontakke NG
    Cureus; 2023 Sep; 15(9):e46135. PubMed ID: 37900501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Siblings with the adult-onset slowly progressive type of pantothenate kinase-associated neurodegeneration and a novel mutation, Ile346Ser, in PANK2: clinical features and (99m)Tc-ECD brain perfusion SPECT findings.
    Doi H; Koyano S; Miyatake S; Matsumoto N; Kameda T; Tomita A; Miyaji Y; Suzuki Y; Sawaishi Y; Kuroiwa Y
    J Neurol Sci; 2010 Mar; 290(1-2):172-6. PubMed ID: 20006850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders.
    Iankova V; Karin I; Klopstock T; Schneider SA
    Front Neurol; 2021; 12():629414. PubMed ID: 33935938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic features of PKAN patients in a tertiary centre in Turkey.
    Akcakaya NH; Iseri SU; Bilir B; Battaloglu E; Tekturk P; Gultekin M; Akar G; Yigiter R; Hanagasi H; Alp R; Cagirici S; Eraksoy M; Ozbek U; Yapici Z
    Clin Neurol Neurosurg; 2017 Mar; 154():34-42. PubMed ID: 28113101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of disease progression in atypical form of pantothenate-kinase-associated neurodegeneration (PKAN) - Prospective study.
    Tomić A; Petrović I; Svetel M; Dobričić V; Dragašević Mišković N; Kostić VS
    Parkinsonism Relat Disord; 2015 May; 21(5):521-4. PubMed ID: 25724846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel
    Li WB; Shen NX; Zhang C; Xie HC; Li ZY; Cao L; Chen LZ; Zeng YJ; Fan CX; Chen Q; Shi YW; Song XW
    Front Aging Neurosci; 2022; 14():848919. PubMed ID: 35462688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Nonsense Mutation in
    Ghafouri-Fard S; Yassaee VR; Rezayi A; Hashemi-Gorji F; Alipour N; Miryounesi M
    Int J Mol Cell Med; 2016; 5(4):255-259. PubMed ID: 28357202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyslipidemia and hypercalciuria in a patient with pantothenate kinase 2 deficiency: A novel variant and case report.
    Rodriguez-Perez HM; Reyes-Flores OB; Quiñonez-Pacheco Y; Centeno-Navarrete YA; Gonzalez-Vazquez C; Campos-Garcia FJ
    SAGE Open Med Case Rep; 2024; 12():2050313X241249088. PubMed ID: 38680600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel homozygous variation in the
    Habibi AH; Razmeh S; Aryani O; Rohani M; Taghavian L; Alizadeh E; Kokhedan KM; Zaribafian M
    Neurol Int; 2019 Mar; 11(1):7959. PubMed ID: 30996846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acanthocytosis and the c.680 A>G Mutation in the PANK2 Gene: A Study Enrolling a Cohort of PKAN Patients from the Dominican Republic.
    Schiessl-Weyer J; Roa P; Laccone F; Kluge B; Tichy A; De Almeida Ribeiro E; Prohaska R; Stoeter P; Siegl C; Salzer U
    PLoS One; 2015; 10(4):e0125861. PubMed ID: 25915509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Scale to Assess Activities of Daily Living in Pantothenate Kinase-Associated Neurodegeneration.
    Marshall RD; Collins A; Escolar ML; Jinnah HA; Klopstock T; Kruer MC; Videnovic A; Robichaux-Viehoever A; Swett L; Revicki DA; Bender RH; Lenderking WR
    Mov Disord Clin Pract; 2019 Feb; 6(2):139-149. PubMed ID: 30838313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.